Viridian Therapeutics, Inc. · NASDAQ:VRDN

Fairmount Healthcare Fund II L.P. bought 1,176,470 Viridian Therapeutics, Inc. shares (Form 4)

Traded May 11, 2026 · Filed May 13, 2026

On May 11, 2026, Fairmount Healthcare Fund II L.P. (Director, 10% owner) bought 1,176,470 Viridian Therapeutics, Inc. shares at US$17.00 for US$20M, leaving 5,090,928 shares. Filed May 13, 2026 (Form 4).

Bought
1,176,470 shares
Price
US$17.00
Value
US$20M
Holding after
5,090,928 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 11, 2026Common StockBuy1,176,470US$17.005,090,928Indirect

Source

View original at SEC

Related